Cargando…
Estimating the efficacy of pharmacogenomics over a lifetime
It is well known that common variants in specific genes influence drug metabolism and response, but it is currently unknown what fraction of patients are given prescriptions over a lifetime that could be contraindicated by their pharmacogenomic profiles. To determine the clinical utility of pharmaco...
Autores principales: | Ye, Zhan, Mayer, John, Leary, Emili J., Kitchner, Terrie, Dart, Richard A., Brilliant, Murray H., Hebbring, Scott J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645151/ https://www.ncbi.nlm.nih.gov/pubmed/38020121 http://dx.doi.org/10.3389/fmed.2023.1006743 |
Ejemplares similares
-
Validation of PhenX measures in the personalized medicine research project for use in gene/environment studies
por: McCarty, Catherine A, et al.
Publicado: (2014) -
Development of an Integrated Platform Using Multidisciplinary Real‐World Data to Facilitate Biomarker Discovery for Medical Products
por: Dabic, Stefan, et al.
Publicado: (2019) -
Estimating the Lifetime Benefits of Treatments for Heart Failure
por: Ferreira, João Pedro, et al.
Publicado: (2020) -
Implementation of Pharmacogenomic Information on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Tsukagoshi, Eri, et al.
Publicado: (2021) -
Identifying genetically driven clinical phenotypes using linear mixed models
por: Mosley, Jonathan D., et al.
Publicado: (2016)